MD Anderson names new vice provost, clinical and interdisciplinary...
MD Anderson News Release 06/30/2015
The University of Texas MD Anderson Cancer Center is pleased to announce the appointment of...
Similarities between embryos and breast tumors identified
MD Anderson researchers find that metastatic tumors behave like embryonic stem cells
MD Anderson News Release 06/30/2015
Tiny particles in blood useful for early diagnosis of...
MD Anderson study shows promise for Glypican-1 in identifying cancer-specific exosomes
MD Anderson News Release 06/24/2015
<...
Keys to prevention: MD Anderson leaders share latest news in fight...
Making Cancer History® seminar returns to Aspen July 16
MD Anderson News Release 06/24/2015
The University of Texas MD Anderson...
Current blood cancer drug prices not justified, MD Anderson...
MD Anderson News Release 06/22/2015
The costs associated with cancer drug prices have risen dramatically over the past fifteen...
Genomic discovery of skin cancer subtypes provides...
MD Anderson researchers lead The Cancer Genome Atlas analysis of cutaneous melanoma identifying four subtypes
MD Anderson News...
Breast-Conserving Therapy for Early-stage Cancers has...
Largest, most in-depth study to date shows BCT is being used more widely; health policy interventions are needed to address factors...
What’s in a name? “Death-associated protein” promotes cancer...
MD Anderson study identifies DAPK1 protein as a novel therapeutic target in tumors with TP53 mutations
MD Anderson News Release 06...
ADAMTS family of genes may be the next ‘thing’ in ovarian...
MD Anderson study reveals key mutations other than well-known BRCA1/BRCA2 genes
MD Anderson News Release 06/11/2015
MD Anderson study finds gene mutations sensitize tumors to...
Commonly mutated tumor suppressor represents a new target for treating certain cancers
MD Anderson News Release 06/11/2015